Anticancer activity in Planctomycetes by Calisto, Rita et al.
fmars-05-00499 December 24, 2018 Time: 10:23 # 1
ORIGINAL RESEARCH








Helmholtz Center for Infection
Research, Helmholtz Association
of German Research Centres (HZ),
Germany
Paula Branquinho Andrade,





This article was submitted to
Marine Biotechnology,
a section of the journal
Frontiers in Marine Science
Received: 19 April 2018
Accepted: 11 December 2018
Published: 07 January 2019
Citation:
Calisto R, Sæbø EF,
Storesund JE, Øvreås L, Herfindal L
and Lage OM (2019) Anticancer
Activity in Planctomycetes.




Rita Calisto1,2, Eirik Færøy Sæbø3, Julia E. Storesund3, Lise Øvreås3,4, Lars Herfindal5
and Olga M. Lage1,2*
1 Department of Biology, Faculty of Sciences, University of Porto, Porto, Portugal, 2 Interdisciplinary Centre of Marine
and Environmental Research, University of Porto, Porto, Portugal, 3 Department of Biological Sciences, University of Bergen,
Bergen, Norway, 4 Department of Arctic Biology, University Centre in Svalbard, Longyearbyen, Norway, 5 Centre
for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway
There is a strong need to develop new drugs against many severe diseases.
Therapy resistance is a major problem, for instance, in infectious diseases and
cancer. Drug discovery has again turned to nature to search for molecules that can
become drug leads. Although many bacterial phyla are extensively studied, some,
like the Planctomycetes, remain largely unexplored as potential sources of new leads.
Planctomycetes form a diverse group of bacteria with peculiar characteristics such as
division by polar budding and absence of the FtsZ gene. Furthermore, they exhibit large
genomes up to 12.5 Mb, and possess a high number of secondary metabolites as
assessed by in silico genomic analysis. These characteristics have also revealed the
presence of potential anticancer activity. Based on these promising characteristics,
we wanted to investigate Planctomycetes as a source for natural products with
anticancer properties. Organic and aqueous extracts were obtained from cultivated
Planctomycetes strains originated from a variety of habitats such as marine systems
(free living or attached to marine algae), deep marine iron hydroxide deposits, brackish
water and glacier ice system. The extracts were screened for ability to inhibit cell growth,
or induce cell death on two cancer cell lines, the human prostatic cancer cell line PC3,
and human acute myeloid leukaemia (AML) cell line MOLM-13, as well as normal rat
kidney epithelial cell line (NRK). Out of 39 strains, five exhibited cytotoxicity toward NRK
cells, whereas 32 of the strains were toxic to the AML cell line, and four were toxic to the
PC3 cell line. Two strains showed high toxicity and selectivity toward both the cancer
cell lines over the NRK-cells, and are potential producers of anti-cancer compounds. We
found no correlation between bioactivity and strains habitat and geographic location but
regarding phylogeny some Rhodopirellula spp. showed higher toxicity toward MOLM-13
cells. These results from the first anticancer screening with Planctomycetes showed that
these peculiar microorganisms should be further explored for anti-cancer compounds,
and that more effort must be put in providing culture collections for drug development
purposes.
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INTRODUCTION
Biotechnological search for new natural products is of utmost
importance for the well-being and sustainability of humanity
in the fight against many deadly diseases such as cancer and
bacterial infections due to development of drug resistance
(O’Neill, 2016). In Europe, cancer represents the second most
important cause of death and morbidity with more than 3.7
million new cases and 1.9 million deaths each year (World Health
Organization, 2012). In the United States, values of 1.7 million
new cancer cases diagnosed and 0.6 million cancer deaths were
estimated for 2017 (Siegel et al., 2017). As the prophylactic
treatment to prevent cardiovascular diseases improves, it is
expected that cancer will become the leading cause of death
within few years (Heron and Anderson, 2016). This increase in
cancer incidents represents new challenges. As the population
ages, there will be a need for novel therapeutics with less harmful
side-effects like cardiac failure or bone marrow depletion, often
associated with therapy-induced mortality in elderly patients.
In the development of new therapeutics, the majority of
drug candidates are natural derived compounds (Imhoff et al.,
2011). Some phyla of bacteria, Actinobacteria, Myxobacteria
and Cyanobacteria, are well known producers of secondary
metabolites (Jeske et al., 2016) and have been extensively studied
for bioactive compounds. Traditionally, terrestrial organisms
have been targeted for the search of novel antibacterial
compounds and secondary metabolites. Therefore, special
attention is directed toward marine biological sources (Joseph
and Sujatha, 2010) and less explored bacterial phyla. The marine
environment is a huge ecosystem still highly underexplored.
It thus represents a vast source for novel bioactive molecules
that can fulfill the ever-increasing need for new therapeutics
to meet the increasing demand of pharmaceuticals. The oceans
are inhabited by an immense diversity of microorganisms
that only recently started to be unveiled. Estimations foresee
numbers exceeding 1029 bacterial cells in the open ocean, with
an average cell concentration of 106 per milliliter of seawater
(Whitman et al., 1998; Amaral-Zettler et al., 2010). It has become
notorious that the study of novel bacterial phyla could lead to
new bioactive molecules (Bredholt et al., 2008). One of these
phylogenetic groups are the Planctomycetes, bacteria that have an
intricate, still not fully understood, cell biology with complex life
cycles and large genomes. Recently, Planctomycetes have proven
the capacity to produce antibiotics and antifungal molecules
and also genome mining has demonstrated their promising
biotechnological potential (Donadio et al., 2007; Jeske et al., 2013;
Graça et al., 2016; Jeske et al., 2016; Boedeker et al., 2017). This
is due to the presence of secondary metabolite genes or clusters
related to various pathways for the production of several bioactive
molecules, including some antitumor compounds like epothilone
(Graça et al., 2016).
Besides the in silico study of its potential, no study has
hitherto addressed the anti-cancer proprieties of Planctomycetes.
In fact, the study presented here is the first anticancer screening
performed with Planctomycetes assessing the induction of
apoptosis and the decrease of growth in cancer cell lines.
Acute myeloid leukemia (AML) cell lines were chosen because
AML is one of the most aggressive forms of leukemia and
is associated with high rate of chemotherapy resistant relapse,
and dose-limiting side-effects. Moreover, therapies developed
toward leukemia have high translational value to other cancers.
We also tested for activity toward a solid tumor derived cell
line, using prostate cancer (PC) cell lines since PC is one
of the most common cancer types and with high mortality
rates, especially in western countries. PC is the leading cause
of death from cancer in United States (Siegel et al., 2017)
and the third most common cause of death in Europe (Bray
and Kiemeney, 2017). The results obtained with both cancer
cell lines (AML and PC) were compared with the ability to
induce cell death in a normal epithelial cell line (NRK). High
toxicity was obtained against AML cells with both aqueous
and organic extracts from several strains whereas a reduced
number of organic extracts were effective against PC cells. Two
organic extracts exhibited high toxicity toward both cancer cell
lines and not toward control NRK cells which makes them two
good candidates for the production of anticancer compounds.
Our results show that Planctomycetes represent a promising




The Planctomycetes strains used in this study were obtained
from several different habitats (Table 1), namely marine
iron hydroxide deposits (13 strains), marine water column
(1 strain), macroalgal surface (18 strains), a meromictic
lake (5 strains) and a glacier ice inside a cave (2 strains).
The strains affiliate to diverse phylogenetic clusters within
the Planctomycetes phylum (Supplementary Figure S1). The
Planctomycetes bacterium strain Pir4_P6_1 and Planctomycetes
bacterium strain Pir4_P6_2 will be here designated as P6_1
and P6_2. The phylogeny of these two strains is allocated
to Pir4 based on the Silva database (Yilmaz et al., 2014).
The type strains of Rhodopirellula baltica, strain SH1T was
isolated from the Kiel Fjord in the Baltic Sea (no GPS
coordinates available). All the Planctomycetes isolated from
Portugal (from the surface of macroalgae in three locations
in the northern coast) were previously described (Lage and
Bondoso, 2011). Strains CcC6, CcC8, FC9.2, FC18, UC8,
UC9, UC13, UC16, UC21, and UC49.1 were collected from
Carreço, Portugal (41◦44′N, 8◦52′W), strains FF4, UF3, UF4.2,
UF6 and Sm4 were collected in Porto, Portugal (41◦09′N,
8◦40′W) and strain Gr7 from Aveiro – 40◦38′N, 8◦52′W. The
strains isolated from marine iron hydroxide deposits (MgM4h,
TBK2h, VLsL2h, VLoJ2h, VLoJ4h, K2D, VLrD4, VLbF2, Plm2,
TBK1, VLsL4r, VLsK4lr, VLpG4r) were obtained from the
South Pacific Ocean (176◦36′W, 22◦10.82′S VaiLili). Detailed
descriptions of locations, strains and isolation procedures are
given in Storesund et al. (2018). The five strains (9mWe,
7mR, 1mW, 8mW, 15mW) collected from the meromictic
lake Sælenvannet south of Bergen, Norway (60◦19N, 05◦16E),
was collected in 2012 using the same sampling protocol as
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described in Ovreås et al. (1997), covering both aerobic surface
layer (1 m) as well as the anaerobic water masses below
the chemocline (7, 8, 9, and 15 m). Two of the strains (L1
and L2) were isolated from the surface of the macroalgae
Saccharina nigripes collected from Hansneset in Kongsfjorden
on Svalbard (78◦59N, 11◦57E), using the protocol described
previously by Bengtsson and Øvreås (2010). Two strains (P6_1
and P6_2) were isolated from a glacier ice situated inside the
cave Svarthammarhola in northern Norway (67◦13′ N, 15◦31′E
at 295 m a.s.l.). The cave system is described in detail by
Lauritzen et al. (2018), ice masses was collected and brought
frozen to the laboratory for further processing as described in
Sæbø (2018).
Identification of Planctomycetes Strains
All strains were identified based on the analysis of the 16S
rRNA gene. The identification of the strains isolated from
Portugal has previously been described (Lage and Bondoso,
2011). For the other strains, full length 16S rRNA gene
sequences were obtained from isolated strains as described
in Storesund and Øvreås (2013). Pure colonies were picked
from plates and transferred to 50 µL sterile water. These cell
slurries were subjected to three cycles of freeze-thawing to lyse
the cells, and these mixtures were then used as template in
the PCR reaction. The 16S rRNA gene was amplified using
the primer combination A8f with 1542r, targeting bacterial
16S rRNA genes. The PCR products were purified using
TABLE 1 | Phylogeny, habitat and location of Planctomycetes strains used in this study.
Strain Phylogeny Habitat Location Country
MgM4h Blastopirellula cremea Iron hydroxide deposits South Pacific Fidji/Tonga
9mWe Blastopirellula cremea Meromictic lake Fana Norway
TBK2h Blastopirellula marina Iron hydroxide deposits South Pacific Fidji/Tonga
VLsL2h Blastopirellula sp. Iron hydroxide deposits South Pacific Fidji/Tonga
VLoJ2h Blastopirellula sp. Iron hydroxide deposits South Pacific Fidji/Tonga
VLoJ4h Blastopirellula sp. Iron hydroxide deposits South Pacific Fidji/Tonga
FC18 Mariniblastus fucicola Fucus spiralis Carreço Portugal
K2D Planctomycetes bacterium Pir 4. Iron hydroxide deposits South Pacific Fidji/Tonga
P6_1 Pir 4 (Ice cluster) Cave Ice Svarthamarhola Norway
P6_2 Pir 4 (Ice cluster) Cave Ice Svarthamarhola Norway
VLrD4 Gimesia maris Iron hydroxide deposits South Pacific Fidji/Tonga
VLbF2 Gimesia maris Iron hydroxide deposits South Pacific Fidji/Tonga
Plm2 Gimesia maris Iron hydroxide deposits South Pacific Fidji/Tonga
UC49.1 Rhodopirellula baltica Ulva sp. Carreço Portugal
SH1 Rhodopirellula baltica Water column Baltic Sea Germany
UC21 Rhodopirellula baltica Ulva sp. Carreço Portugal
L1 Rhodopirellula islandica Saccharina nigripes Kongsfjorden Norway
CcC6 Rhodopirellula lusitana Chondrus crispus Carreço Portugal
CcC8 Rhodopirellula lusitana Chondrus crispus Carreço Portugal
Sm4 Rhodopirellula lusitana Sargassum moticum Porto Portugal
UC13 Rhodopirellula lusitana Ulva sp. Carreço Portugal
UC16 Rhodopirellula lusitana Ulva sp. Carreço Portugal
UF6 Rhodopirellula lusitana Ulva sp. Porto Portugal
L2 Rhodopirellula lusitana Saccharina nigripes Kongsfjorden Norway
UC9 Rhodopirellula rubra Ulva sp. Carreço Portugal
7mR Rhodopirellula sp. Meromictic lake Fana Norway
FC9.2 Rhodopirellula sp. Fucus spiralis Carreço Portugal
FF4 Rhodopirellula sp. Fucus spiralis Porto Portugal
TBK1 Rhodopirellula sp. Iron hydroxide deposits South Pacific Norway
VLsL4r Rhodopirellula sp. Iron hydroxide deposits South Pacific Fiji/Tonga
VLsK4lr Rhodopirellula sp. Iron hydroxide deposits South Pacific Fidji/Tonga
VLpG4r Rhodopirellula sp. Iron hydroxide deposits South Pacific Fidji/Tonga
UC8 Roseimaritima ulvae Ulva sp. Carreço Portugal
UF3 Roseimaritima ulvae Ulva sp. Porto Portugal
UF4.2 Roseimaritima ulvae Ulva sp. Porto Portugal
Gr7 Rubinisphaera brasiliensis Gracilaria bursa-pastoris Aveiro Portugal
1mW Rubinisphaera sp. Meromictic lake Fana Norway
8mW Rubinisphaera sp. Meromictic lake Fana Norway
15mW Rubinisphaera sp. Meromictic lake Fana Norway
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ExoStar as described by manufacturer (USB Corporation), and
subsequently sequenced using Big-Dye.3.1 kit (ABI 3700 PE;
Applied Biosystems). Sequencing was done on an ABI3700
sequencing system (Applied Biosystems) at Bergen Sequencing
facility1.
All 16S rRNA gene sequences of the various strains were
deposited in NCBI database under the following accession
numbers: EF589350.2 (UC16), EF589352.2 (CcC6), HQ845424.1
(CcC8), HQ845450.1 (FC18), HQ845477.1 (Gr7), HQ845503.1
(Sm4), HQ845508.1 (UC8), HQ845509.1 (UC9), HQ845513.1
(UC13), HQ845517.1 (UC21), HQ845532.1 (UF3), HQ845534.1
(UF4.2), HQ845536.1 (UF6), KX495344.1 (FC9.2), KX495345.1
(UC49.1), JN236500.1 (FF4), MH686033 (P6.1), MH686034
(P6.2), MH916628 (9mWe), MH916629 (1mW), MH916630
(8mW), MH916631 (15mW), MH916632 (7mR), MH916640
(L1), MH916641 (L2), MH918141 (MgM4h), MH918142
(TBK2h), MH918143 (VLsL2h), MH918144 (VLoJ2h),
MH918145 (VLoJ4h), MH918146 (K2D), MH918147 (VLrD4),
MH918148 (Plm2), MH918149 (VLbF2), MH918150 (TBK1),
MH918151 (VLsL4r), MH918152 (VLsK4lr), MH918153
(VLpG4r), NC_005027.1 (SH1).
Phylogenetic Analysis of Bacteria
The 16S rRNA gene sequences of the bacteria were alignment
using MEGA 6 (Molecular Evolutionary Genetics Analysis)
software, that permits to infer overtime the molecular
evolutionary between genes, genomes and species (Tamura
et al., 2013). The construction of the phylogenetic tree was
performed the using calculation method maximum likelihood –
ML in MEGA 6, applying General Time Reversible model and
Gamma distributed with Invariant sites (G+I). As outgroup,
Candidatus Scalindua brodae clone EN8 was used.
Cultivation of Planctomycetes
Pure cultures of Planctomycetes were cultivated in 250 mL M13
or M30 media with 70 – 90% seawater with the exception of
the ice derived isolates that were cultivated in M30 with 18%
seawater (Table 1) at 25◦C, and 120 rpm After 7 days incubation,
the cultures were centrifuged for 15 min at 10,000 × g, and
the supernatant discarded. The cell pellets were washed twice
with sterile water and freeze-died for approximately 18 h (with
temperature below – 40◦C and about 4 × 10−2 atm pressure).
The final biomass was weighted and kept at −20◦C until further
processing.
Preparation of Planctomycetes Extracts
for Cell Lines Experiments
Six mL of methanol: MilliQ water: chloroform (1:1:1) were
added to each freeze-dried pellet. Six mL of the mixture without
cells were used as an extraction control. The samples were
homogenized (Tempest Virtishear I.Q. from Virtis, Gardiner NY
fitted with 10 mm rotor), at 20000 rpm, for two periods of 30 s,
with cooling on ice for 10 s between the cycles. The samples were
allowed to extract for 1 h at 4◦C, with agitation after 30 min,
1www.seqlab.uib.no
and then centrifuged at 450 × g for 30 min at 4◦C, to separate
the aqueous and organic phases. For each sample: (i) the organic
phase (bottom phase) was carefully transferred to a separate tube
and evaporated to dryness in a vacuumed centrifuge (Eppendorf
concentrator plus, Eppendorf AG, Hamburg, Germany). The
dried extract was dissolved in DMSO in a ratio of 10 mg of
initial freeze-dried biomass of the bacterial culture to 25 µL
of DMSO. (ii) The aqueous phase (top phase) was treated in a
similar way as the organic extract with the exception of the final
step. The aqueous extracts were added 75 µL of MilliQ water,
in addition to 25 µL DMSO for each 10 mg initial freeze-dried
biomass.
Cancer Cell Lines and Cytotoxicity
Assays
Planctomycetes extracts were tested for their capacity to
induce cell death in the normal epithelial rat kidney cell
line NRK (ATCC no: CRL-6509), the human AML cell
line MOLM-13 (Matsuo et al., 1997; Quentmeier et al.,
2003) and in the human PC cell line PC3 (ATCC no.:
CRL-1435).
MOLM-13 cells were cultured in RPMI medium (Sigma
R5886), supplemented with 10% (v/v) fetal calf serum
(Sigma F7524), 0.2 mM L-glutamine and added 50 IU/mL
penicillin and 0.1 mg/mL streptomycin. The cells were
cultured to a density between 8 and 80 × 104 cells/mL,
and diluted by adding fresh medium with supplements.
NRK and PC3 cells were cultured in Dulbecco’s modified
Eagle’s medium (DMEM - Sigma D-6429), with the same
supplements as for MOLM-13 cells. The PC3 and NRK cells
are adherent, and at 90% confluence, the cells were detached
by mild trypsin treatment (0.30 mg/mL trypsin for 5 min
at 37◦C) and reseeded in fresh medium with supplements
at 40–50% confluence. Cells were incubated at 37◦C, in a
humidified atmosphere with 5% CO2. All media, serum and
supplements, and reagents were from Sigma-Aldrich, St. Louis,
MO, United States.
The cytotoxicity experiments were performed in 96-well
plates. One hundred µL containing 6000 cells of NRK or PC3
cell lines were placed in each well 24 h before the addition of the
extracts to allow cells attachment to the substratum. After 24 h
the medium was replaced by fresh medium and the extracts were
added. MOLM-13 cell suspensions (20,000 cells/well in 100 µL)
were added to the plates at the same time as the extracts. For all
cell lines, 1 µL of the organic extracts or 4 µL of the aqueous
extracts were added, respectively, to 99 or 96 µL of cell culture.
The same volume of DMSO was used as solvent control and a
negative control of 100 µL cell culture was also made. Cells were
incubated with the extracts for 72 h. The viability of the cells was
first monitored using the WST-1 assay metabolic assay (Roche,
Mannheim, Germany) following the manufacturers instruction.
Thereafter, the cells were fixed with 2% buffered formaldehyde
(pH 7.4) containing 0.01 mg/mL of the DNA-specific fluorescent
dye, Hoechst 33342 and morphology of the nuclei was visualized
by fluorescence microscopy (Nikon Diaphot 300 fitted with a
40× Flu-Phase contrast lens and a DS-Fi3 camera) as described
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FIGURE 1 | Heat-map showing the different degrees of toxicity that organic and aqueous extracts of Planctomycetes induced in NRK, MOLM-13 and PC3 cell lines.
From strain L2, extracts were obtained after 7 and 15 days of cultivation [L2 and L2(2), respectively]. Heat-map scale: 0–20% – no toxicity; 20–40% – low toxicity;
40–70% – intermediate toxicity; 70–100% – high toxicity. White boxes – Not evaluated. Graph was created in R studio program, using pheatmap package. Cluster
analysis was based on Euclidean Distance.
by Prestegard et al. (2009). A minimum of hundred cells from
each cell line were used to determine cell death microscopically.
All extracts were tested for cytotoxic activity 3–5 times for each
concentration. The combination of WST-1 assay and microscopic
evaluation has previously been shown to give reliable results
(Vu et al., 2016; Viktorsson et al., 2017) and also complement
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each other. WST-1 can detect growth inhibitory activity, and the
nuclear evaluation is particularly useful if working with colored
extracts.
Statistical Analysis
Statistical analyses and visualization was done in R (R Core Team,
2017) using the vegan (Oksanen et al., 2015), ggplot2 (Wickham,
2009) and pheatmap packages (Kolde, 2015).
To see if the toxic effect of Planctomycetes on the
different cancer cell lines was related to strain phylogeny
(Blastopirellula, Gimesia, Mariniblastus, Rhodopirellula sp.,
Rhodopirellula lusitana, Roseimaritima, Rubinisphaera or Pir
4) or original habitat (ice, iron hydroxides, meromictic lake,
macroalgal surface or seawater) we used analysis of similarities
(ANOSIM, vegan). The response variable was a dissimilarity
matrix of individual strain effects (aqueous and organic, n = 6)
on the three cancer cell lines, and the predictors were strain
phylogenetic affiliation and original habitat. A PCA analysis (999
perm) was used to further examine correlations between strain
toxicity and the different cell lines.
RESULTS
A total of 39 Planctomycetes were screened for cytotoxic
bioactivity toward human AML cell line (MOLM-13) and human
prostatic cancer cell line (PC3). The normal rat kidney epithelial
cell line (NRK) was used to be able to distinguish between
general cytotoxic activity (all three cell lines affected), and
anti-cancer activity (cancer cell lines affected, but not NRK
cell lines). All cells were analyzed for metabolic activity using
the WST-1 assay which measures enzymatic conversion of a
tetrazolium salt into a colored metabolite. However, as several
of the Planctomycetes possess coloration that interferes with
the WST-1 colorimetric assay, cytotoxicity was therefore only
assessed through the nuclear morphology (see Supplementary
Figure S2).
All the Planctomycetes were cultivated for 7 days except strain
L2, which was also grown for 15 days to assess a longer stationary
phase on the potential production of bioactive molecules.
The extracts were tested at 1% for the organic extracts and
4% for the aqueous extracts, both corresponding to extracts from
0.4 mg freeze-dried material per 0.1 mL cell culture medium.
First, it was tested whether the extracts exhibited cytotoxicity
during 24-h incubation. However, we noticed only modest
cytotoxicity for all extracts after this incubation time. Since many
cytostatics, like metabolic inhibitors, have a protracted cytotoxic
effect, we decide to incubate the cells with the Planctomycetes
extracts for 72 h before assessing for cell death. We divided
the cytotoxic potential of the extracts into high - H (>70%
cell death), intermediate – I (40–70% cell death), low - L
(20–40% cell death) or no (<20% cell death) (Supplementary
Table S1). In total, 40 aqueous and 40 organic extracts were
analyzed. The different cell lines were screened under the
microscope for apoptotic nuclei and their percentage calculated
(Supplementary Figure S2). Based on these values, a heat-
map of the cytotoxic effects was constructed (Figure 1). The
FIGURE 2 | Boxplots indicate the effects in % cell death on cancer cell lines
(PC3 and MOLM-13) and controls (NRK) in aqueous (A) and organic phase (O)
of strains affiliating with different subgroups of Planctomycetes. The band
inside each box represents the median and the black points indicate values
for individual strains.
organic extracts showed higher cytotoxic capacity than the
aqueous extracts both in number (55% of the organic and 35%
of the aqueous) and intensity (mean and median cell death
Frontiers in Marine Science | www.frontiersin.org 6 January 2019 | Volume 5 | Article 499
fmars-05-00499 December 24, 2018 Time: 10:23 # 7
Calisto et al. Anticancer Activity in Planctomycetes
was, respectively, 26.4 and 12.1% for the organic and 13.6 and
6.0% for the aqueous extracts) (Figure 1 and Supplementary
Table S1).
Only five extracts showed intermediate or high activity toward
NRK cells; the aqueous extract from strain Plm2, and the
organic extracts from strains 7mR, SH1, UC49.1 and Sm4. High
or intermediate activity toward PC3 prostate cancer cells was
detected only in the organic extracts from strains CcC6, L1,
SH1, Sm4, UC16, and UC49.1. Of these, strains SH1, Sm4
and UC49.1 were also cytotoxic toward NRK cells, but strains
CcC6 and L1 appeared selective toward PC3 cells over NRK
cells.
In general the MOLM-13 cells were much more sensitive
toward the planctomycetal extracts than the other two cell
lines. When counting strains causing high and intermediate
cytotoxicity, 18% of the strains were H, and 43% I in the organic
extracts, and 13% were H, and 25% I in the aqueous extracts.
Only strains P6.1, VLbF2, 1mW, VLsL2h, VLoJ2h, and VLpG4r
produced cytotoxic activity in both extracts, the remaining strains
had cytotoxicity in only one of the extracts.
From strain L2, extracts were obtained after 7 and 15 days of
cultivation. After 7 days the organic extract was bioactive against
MOLM-13 with low cytotoxicity (24%) but after the 15 days a
threefold increase in cytotoxicity (70%) was seen (Figure 1 and
Supplementary Table S1).
Some strains stood out as particularly promising regarding
anticancer activity. The organic extracts from the Rhodopirellula
lusitana strains CcC6 (H – 83% PC3 and I – 72% MOLM-13)
and Rhodopirellula sp. L1 (H – 87% PC3 and I – 59% MOLM-
13) induced cell death in the cancer cell lines selectively, i.e.,
strong activity toward both cancer cell lines, but not NRK-
cells (Figure 1 and Supplementary Table S1). Another striking
feature was that several Planctomycetes were selective toward
MOLM-13 cells only, such as Rhodopirellula lusitana strain CcC8
(I – 67%), UC13 (H – 91%) and Gimesia maris VLrD4 (I –
44%) only in the organic phase. Furthermore, Rhodopirellula
sp. VLpG4r (I (aq) – 50 % and I (org) – 43 %), Pir4_P6_1 (I
(aq) – 64 % and I (org) – 56 %), Rubinisphaera sp. 1MW (H
(aq) – 78 % and I (org) – 46 %), Gimesia maris VLbF2 (H
(aq) – 76% and I (org) – 64 %), Blastopirellula sp. VLsL2h (I
(aq) – 69 % and I (org) – 53%) and Blastopirellula sp. VLoJ2h
(I (aq) – 44 % and I (org) – 41%) showed activity both in
aqueous and organic phases. R. lusitana seems to be highly
bioactive in the organic extracts but not in the aqueous extracts
(Figure 2). The most cytotoxic strains belong to Rhodopirellula
spp. (Figure 2).
In this study, a broad range of phylogenetic different
Planctomycetes was selected covering diverse habitats and
geographical origins (Table 1 and Supplementary Figure S1).
Effects of individual strains on cancer cell lines differed between
different phylogenetic groups (ANOSIM, p < 0.005), with
Rhodopirellula sp. and R. lusitana, in particular, showing higher
toxicity toward MOLM-13 cells. However, no distinct patterns
regarding habitat or geographical location (data not shown)
were identified. In line with the ANOSIM analysis, PCA analysis
also showed that the organic extracts from Rhodopirellula
sp. and R. lusitana as well as Rubrinisphaera strains had
stronger effects on MOLM-13 cells than aqueous extracts
(Figure 3). However, the opposite was the case for the extracts
from Blastopirellula, Gimesia, Pir 4 and Rubinisphaera strains
(Figure 3).
DISCUSSION
In this study, we have demonstrated the capacity of
Planctomycetes to induce apoptosis and decrease cell
growth in human and rat cell lines. A considerable number
of Planctomycetes strains contained bioactivity which was active
toward one or both cancer cell lines (MOLM-13 AML cells and
PC3 prostate cancer, but not to the normal NRK kidney epithelial
cells. Moreover, a higher number of Planctomycetes were able
to affect the MOLM-13 cells (32 strains) compared to the PC3
cells (six strains). We have thus showed that Planctomycetes
exhibit anti-cancer activity that could become useful in future
drug development.
Little is known about bioactive substances in Planctomycetes,
as compared to other microorganisms such as Actinobacteria,
Myxobacteria, and Cyanobacteria. However, Planctomycetes
have recently been recognized as important producers of
bioactive compounds by both in silico genome mining analyses
and molecular screening approaches. These analyses revealed
the presence of genes related to various pathways for the
production of several bioactive molecules, including some
antitumor compounds like epothilone (Donadio et al., 2007;
Graça et al., 2013; Wang et al., 2014; Graça et al., 2016; Ivanova
et al., 2017; Vollmers et al., 2017). It is therefore very promising
that several of our Planctomycetes strains isolated from various
ecosystems showed significant cytotoxic activity toward the
MOLM-13 cells and the human prostatic PC3 cells.
FIGURE 3 | Principal component analyses (PCA) constructed from a distance
matrix based on the effect of the individual strains on the different cell lines.
The figure illustrates the relationship between strains, their phylogenetic
affiliation, their original environment and activity against the different cell lines
in aqueous and organic phases. Axis 1 and 2 explains 50 and 23%
respectively of the observed variance. Arrows indicate the correlation between
strains and activity against cell lines.
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The cultivation of Planctomycetes is challenging as they are
slow growing bacteria and therefore production of intermediate
and high scale of biomass is not always straightforward. In this
study we were able to establish growth conditions that allowed
considerable biomass production. For strain L2 a prolonged
growth period (15 days instead of 7 days) was included and
results from this experiment seemed to favor the formation of
bioactive molecules (Figure 1). It should be emphasized that in
both situations the cultures were in the same stationary growth
phase. The only differences are the duration for the production
of bioactive molecules or an increased stress by the aging of the
culture. Planctomycetal growth time is therefore an important
parameter to be considered in future work.
Four strains induced high toxicity (>70%) against NRK
control cells. Interestingly, strain UC49.1 was highly toxic
toward all cell lines in the organic extract, but produced no
toxic substances in the aqueous extracts toward any of the
cell lines. This demonstrates that the two obtained extracts,
aqueous and organic, were different regarding the composition
on Planctomycetes metabolites, similar to what has been
demonstrated for cyanobacteria (Liu et al., 2014; Humisto et al.,
2015). Still six strains showed activity in both extracts (>40%),
which is likely to be caused by compounds with intermediate
hydrophobicity present in both extracts.
The MOLM-13 cells were in general more sensitive toward
the extracts compared to the PC cells (Figure 1). We have
previously observed that the activity toward the MOLM-13 cells
in the aqueous extracts can be due to high levels of adenosine
(Prestegard et al., 2009; Liu et al., 2014). Adenosine has been
shown to induce apoptosis in MOLM-13 cells (Tanaka et al.,
1994). However, in our study, we used non-heat inactivated
fetal bovine serum, where adenosine deaminase is intact, and
able to convert adenosine into the inactive metabolite inosine.
Thus, the anti-AML activity seen in the aqueous extracts in our
experimental assays could not be due to adenosine. The selectivity
toward AML compared to NRK or PC3 could be due to the
more rapid proliferation rate of MOLM-13 cells, and could point
toward a mode of action related to DNA replication or the mitotic
machinery.
The most promising results regarding the anticancer activity
were obtained with the organic extracts from the R. lusitana
strains (CcC6 and L1, Figure 1). They showed activities toward
both MOLM-13 cells and PC3 cells, but not toward the NRK cells.
Interestingly the phylogenetic related R. baltica also produced
extracts showing high toxicity toward the cancer cell lines but
also against the NRK cells. This demonstrates the importance of a
broad culture collection for bioprospecting purposes, since even
highly related strains can give very different bioactivities.
We did not find a strong correlation between biogeography
or habitat of the most promising candidates, as L1 was
isolated from a kelp surface from Kongsfjorden in the
Arctic (Svalbard, Norway), whereas the CcC6 was isolated
from the surface of Chondrus crispus of the Coast of
Portugal. The cytotoxicity-producing Planctomycetes
were ubiquitously distributed and adapted to tolerate
fluctuations in salinity, temperatures, light and nutrient
regimes.
This work further confirms the potential of Planctomycetes
as producers of important bioactivities by extending them to the
production of anti-cancer compounds. Planctomycetes attached
to algal surfaces seemed to be most active toward the cell lines
tested as they produced the most potent anti-cancer compounds
in this study. This could be explained by the high level of
competition in the complex environments of the macroalgal
biofilms against other eukaryotic colonizers, which then might
trigger Planctomycetes production of secondary metabolites. The
production of chemicals toward their eukaryotic competitors
may be fundamental to fight for their niche overcoming their slow
growth rate. Therefore, these metabolites could selectively target
cell signaling component exclusively found in eukaryotes. If these
targets are evolutionary conserved, they might even be present
in mammalian cells. Hitherto interspecies interactions of algae
and bacteria and their resulting natural products are not well
understood. As these bioactive molecules have the potential to be
used for medical purposes, this study enlightens the importance
of exploring molecules produced by Planctomycetes for drug
development. In the light of the evolutionary history, large
genome size and diverse metabolic pathways, we foresee that
several unique and important compounds may appear in these
enigmatic bacteria.
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FIGURE S1 | Phylogenetic 16S rRNA gene tree generated by maximum-likelihood
analysis based in General Time Reversible model and Gamma distributed with
Invariant sites (G+I) indicating the relationship of the Planctomycetes strains
tested in this work. Bar – 0.05 substitutions per 100 nucleotides. The
planctomycete Candidatus Scalindua brodae was used as outgroup.
FIGURE S2 | Examples of MOLM-13 cells stained with the DNA binding specific
Hoechst dye. (A) Control cells and (B) cells exposed to organic extracts of strain
UC49.1. The apoptotic nuclei are bright, condensed or fragmented.
TABLE S1 | Data based on the different degrees of toxicity used for the
construction of the heat-map.
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